Announcements Trials
Browse Landscape

Status

Completed 4Withdrawn 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Iron Overload 1Hemoglobinopathies 1Fibrous Dysplasia, Polyostotic 1Fibrous Dysplasia of Bone 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Glucose Tolerance Test × Clear all
NCT03520153 2019-09-04

Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome

Yale University

Withdrawn

Diabetes Mellitus, Fibrous Dysplasia of Bone, Fibrous Dysplasia, Polyostotic

NCT03141398 2017-07-26

CGMs

Hamad Medical Corporation

Withdrawn
LymphoidOther hematologic neoplasm

Hemoglobinopathies, Lymphoma, Iron Overload, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡